Insmed(INSM) Prnewswire·2024-11-06 13:00Company Overview - Insmed Incorporated is a global biopharmaceutical company focused on delivering first- and best-in-class therapies for patients with serious diseases [4][5] - The company is advancing a diverse portfolio of approved and investigational medicines, particularly in pulmonary and inflammatory conditions [4] - Insmed is recognized as one of the best employers in the biopharmaceutical industry, having been named the No. 1 Science Top Employer for four consecutive years [5] Upcoming Investor Conferences - Insmed will present at the Guggenheim's Inaugural Healthcare Innovation Conference in Boston on November 11, 2024, at 1:00 p.m. ET [1] - The company will also participate in the UBS Global Healthcare Conference in California on November 12, 2024, at 11:45 a.m. PT / 2:45 p.m. ET [2] - Additional presentations include the Wolfe Research Healthcare Conference in New York on November 20, 2024, at 8:00 a.m. ET and the Jefferies London Healthcare Conference on November 21, 2024, at 8:30 a.m. GT / 3:30 a.m. ET [2] Webcast Information - The events will be webcast live and accessible via the investor relations section of Insmed's website [3] - Webcasts will be archived for 30 days following the live events [3]